| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $62.6B | $63.6B | $58.5B | $100.3B | $81.3B | $41.9B | $51.8B | $53.6B |
| Cost of Revenue | $16.1B | $17.9B | $25.0B | $34.3B | $30.8B | $8.7B | $10.2B | $11.2B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $13.8B | $14.7B | $14.8B | $13.7B | $12.7B | $11.6B | $14.3B | $14.5B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $7.8B | $8.0B | $2.1B | $31.4B | $22.0B | $9.6B | $16.3B | $11.2B |
| EPS (Basic) | $1.37 | $1.42 | $0.38 | $5.59 | $3.92 | $1.73 | $2.92 | $1.90 |
| EPS (Diluted) | $1.36 | $1.41 | $0.37 | $5.47 | $3.85 | $1.71 | $2.87 | $1.87 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $208.2B | $213.4B | $226.5B | $197.2B | $181.5B | $154.2B | $167.5B | $159.4B |
| Current Assets | $42.9B | $50.4B | $43.3B | $51.3B | $59.7B | $35.1B | $32.8B | $49.9B |
| Cash & Equivalents | $1.1B | $1.0B | $2.9B | $0.4B | $1.9B | $1.8B | $1.3B | $1.1B |
| Total Liabilities | $121.4B | $124.9B | $137.2B | $101.3B | $104.0B | $90.8B | $104.0B | $95.7B |
| Current Liabilities | $37.0B | $43.0B | $47.8B | $42.1B | $42.7B | $25.9B | $37.3B | $31.9B |
| Stockholders' Equity | $86.5B | $88.2B | $89.0B | $95.7B | $77.2B | $63.2B | $63.1B | $63.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $11.7B | $12.7B | $8.7B | $29.3B | $32.6B | $14.4B | $12.6B | $15.8B |
| Investing Cash Flow | $-1.4B | $2.7B | $-32.3B | $-15.8B | $-22.5B | $-4.3B | $-3.9B | $4.5B |
| Capital Expenditures | $2.6B | $2.9B | $3.9B | $3.2B | $2.7B | $2.3B | $2.2B | $2.0B |
| Financing Cash Flow | $-10.3B | $-17.1B | $26.1B | $-14.8B | $-9.8B | $-9.6B | $-8.5B | $-20.4B |